Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression
- PMID: 28367075
- PMCID: PMC5345332
- DOI: 10.2174/1389202917666160803165229
Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression
Abstract
Accumulating evidence shows that hallmarks of cancer include: "genetic and epigenetic alterations leading to inactivation of cancer suppressors, overexpression of oncogenes, deregulation of intracellular signaling cascades, alterations of cancer cell metabolism, failure to undergo cancer cell death, induction of epithelial to mesenchymal transition, invasiveness, metastasis, deregulation of immune response and changes in cancer microenvironment, which underpin cancer development". Natural compounds as bioactive ingredients isolated from natural sources (plants, fungi, marine life forms) have revolutionized the field of anticancer therapeutics and rapid developments in preclinical studies are encouraging. Natural compounds could affect the epigenetic molecular mechanisms that modulate gene expression, as well as DNA damage and repair mechanisms. The current review will describe the latest achievements in using naturally produced compounds targeting epigenetic regulators and modulators of gene transcription in vitro and in vivo to generate novel anticancer therapeutics.
Keywords: Chromatin; DNA methylation; Epigenetics; Histone acetylation; Histone methylation; Natural compounds; Tumorigenesis; microRNA.
Similar articles
-
Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites.Cell Mol Biol (Noisy-le-grand). 2015 Oct 30;61(6):62-8. Cell Mol Biol (Noisy-le-grand). 2015. PMID: 26518897 Review.
-
Epigenomics in stress tolerance of plants under the climate change.Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9. Mol Biol Rep. 2023. PMID: 37294468 Review.
-
DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions.Biomolecules. 2019 Jul 18;9(7):289. doi: 10.3390/biom9070289. Biomolecules. 2019. PMID: 31323834 Free PMC article. Review.
-
Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.Top Curr Chem. 2013;329:73-132. doi: 10.1007/128_2012_360. Top Curr Chem. 2013. PMID: 22955508 Review.
-
Cancer epigenetics: Past, present and future.Semin Cancer Biol. 2022 Aug;83:4-14. doi: 10.1016/j.semcancer.2021.03.025. Epub 2021 Mar 31. Semin Cancer Biol. 2022. PMID: 33798724 Review.
Cited by
-
Epigenomic Hard Drive Imprinting: A Hidden Code Beyond the Biological Death of Cancer Patients.J Cancer Prev. 2017 Dec;22(4):211-218. doi: 10.15430/JCP.2017.22.4.211. Epub 2017 Dec 30. J Cancer Prev. 2017. PMID: 29302578 Free PMC article. Review.
-
Alpha Ketoglutarate Downregulates the Neutral Endopeptidase and Enhances the Growth Inhibitory Activity of Thiorphan in Highly Aggressive Osteosarcoma Cells.Molecules. 2022 Dec 22;28(1):97. doi: 10.3390/molecules28010097. Molecules. 2022. PMID: 36615293 Free PMC article.
-
Epigenetic Regulation and Dietary Control of Triple Negative Breast Cancer.Front Nutr. 2020 Sep 8;7:159. doi: 10.3389/fnut.2020.00159. eCollection 2020. Front Nutr. 2020. PMID: 33015128 Free PMC article. Review.
-
Therapy-related acute myeloid leukemia and its prevention.Am J Blood Res. 2020 Dec 15;10(6):416-433. eCollection 2020. Am J Blood Res. 2020. PMID: 33489451 Free PMC article. Review.
-
Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy.Mar Drugs. 2020 Dec 31;19(1):15. doi: 10.3390/md19010015. Mar Drugs. 2020. PMID: 33396307 Free PMC article. Review.
References
-
- Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. - PubMed
-
- Floor S.L., Dumont J.E., Maenhaut C., Raspe E. Hallmarks of cancer: of all cancer cells, all the time? Trends Mol. Med. 2012;18:509–515. - PubMed
-
- Plass C., Pfister S.M., Lindroth A.M., Bogatyrova O., Claus R., Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat. Rev. Genet. 2013;14(11):765–780. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources